Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.

Adjuvant chemotherapy has been a component of adjuvant therapeutic strategy for women with breast cancer owing to the observation that adjuvant chemotherapy yielded a significant trend toward the benefit for DFS and OS. 30 As compared with single-agent chemotherapy, significant progression-free survival (PFS) and OS benefits resulted from CMF polychemotherapy. 31 The incorporation of anthracycline agents and taxane including docetaxel and paclitaxel into adjuvant paradigm has been permitted for further improvements in spite of potential risk for increasing adverse effects. 30 , 32 However, the diverse effects of breast cancer subtypes were infrequently referred and discussed.

also in 9,775 other papers